Qube Research & Technologies (QRT)
LABD icon

Qube Research & Technologies (QRT)’s Direxion Daily S&P Biotech Bear 3X ETF LABD Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio LABD Stock Details LABD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$93.2K Sell
5,719
-57,119
-91% -$1.08M ﹤0.01% 3072
2025
Q4 		$1.32M Buy
62,838
+38,528
+158% +$1.04M ﹤0.01% 2438
2025
Q3 		$983K Buy
+24,310
New +$1.41M ﹤0.01% 2520
2025
Q1 		– Sell
-39
Closed -$2.8K – 3706
2024
Q4 		$2.8K Sell
39
-5
-11% -$306 ﹤0.01% 3353
2024
Q3 		$2.55K Sell
44
-86
-66% -$5.22K ﹤0.01% 3169
2024
Q2 		$9.56K Buy
130
+92
+242% +$7.76K ﹤0.01% 2967
2024
Q1 		$2.78K Hold
38
– – ﹤0.01% 3967
2023
Q4 		$3.69K Sell
38
-4
-10% -$778 ﹤0.01% 3761
2023
Q3 		$8.55K Sell
42
-121
-74% -$19.7K ﹤0.01% 3351
2023
Q2 		$50.4K Buy
+163
New +$24.3K ﹤0.01% 2071
2022
Q3 		– Sell
-16
Closed -$6K – 2779
2022
Q2 		$6K Sell
16
-38
-70% -$19.1K ﹤0.01% 2344
2022
Q1 		$19K Sell
54
-181
-77% -$70.9K ﹤0.01% 2256
2021
Q4 		$61K Sell
235
-25
-10% -$5.75K ﹤0.01% 2225
2021
Q3 		$55K Buy
260
+52
+25% +$11.1K ﹤0.01% 1867
2021
Q2 		$40K Buy
208
+153
+278% +$34.3K ﹤0.01% 2041
2021
Q1 		$12K Buy
+55
New +$10.7K ﹤0.01% 1834

Other funds holding LABD

IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
CCM
Capstone Capital Management Hong Kong $224M AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
CF
Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
GS
GTS Securities New York $2.83B AUM 21.76% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Qube Research & Technologies (QRT)'s LABD Position: Q1 2026 in Review

Qube Research & Technologies (QRT) reduced its Direxion Daily S&P Biotech Bear 3X ETF (LABD) stake by 91% in Q1 2026, selling an estimated $1.08M and leaving 5,719 shares worth $93.2K. The position accounts for ﹤0.01% of the portfolio, ranked #3072.

Qube Research & Technologies (QRT) first reported a position in LABD in Q1 2021 and has held it in 16 quarters since. The position peaked at $1.32M in Q4 2025. 17 funds tracked by Wall St. Rank hold LABD as of Q1 2026.

  • Qube Research & Technologies (QRT) held 5,719 shares of Direxion Daily S&P Biotech Bear 3X ETF worth $93.2K as of Q1 2026.
  • Qube Research & Technologies (QRT) sold 57,119 Direxion Daily S&P Biotech Bear 3X ETF shares in Q1 2026, an estimated $1.08M.
  • Direxion Daily S&P Biotech Bear 3X ETF made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q1 2026, its #3072 holding.
  • Qube Research & Technologies (QRT) first reported a position in Direxion Daily S&P Biotech Bear 3X ETF in Q1 2021 and has held it in 16 quarters since.
  • Qube Research & Technologies (QRT)'s Direxion Daily S&P Biotech Bear 3X ETF position peaked at $1.32M in Q4 2025.
  • 17 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bear 3X ETF as of Q1 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.